Stilla Technologies expands in the U.S. via a strategic distribution relationship with Avantor, making their digital PCR products more accessible. Stilla broadens its offerings to include Cell and Gene Therapy, biopharma quality control, infectious diseases, and applied testing. A recent study by Meierrieks et al. revealed that Stilla’s Crystal Digital® PCR with the Ruby Chip […]
Facility will bring together 135 employees across several departments into one collaborative state-of-the-art space. Facility to provide production-related quality control services for Life Science business Brings together 135 employees and various functions into one ~10,000 m2 building Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY — Merck, a leading […]
Cunningham previously served as CCO for Exact Sciences and brings more than20 years of commercial leadership across healthcare tech, life sciences, and pharma SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the appointment of Everett Cunningham as Chief Commercial Officer (CCO), effective June 10. Cunningham will be responsible […]
Move reflects increasing investment in AI as driving force for innovation and productivity. Company will host Innovation Summit in December focused on AI in R&D. WASHINGTON — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced the creation of the new role of Chief Data & Artificial Intelligence (AI) Officer and the […]
New QIAcuity digital PCR Custom Assay Design Tool for copy number variation analysis supports researchers’ customization needs, complementing QIAGEN’s existing pre-designed assays GeneGlobe Design and Analysis Hub receives further enhancements, improving user experience and capabilities to design panels collaboratively Advancements strengthen QIAGEN as a trusted partner for researchers, catering to their diverse needs to further […]
SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments. “We are excited to deliver for our NextSeq 1000/2000 customers improved sequencing with faster run times, […]
Siren Biotechnology to receive products, technologies and contract testing services to develop gene therapy treatments for cancer Experts from MilliporeSigma’s Emprove® team and M Lab™ Collaboration Center to provide consultation and training Company has awarded grants to 40-plus biotechnology companies since 2014 BURLINGTON, Mass. — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, […]
Providing rights to academic research globally aimed at enabling solutions to complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta Syngenta Group, one of the world’s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies for […]
ZYMO RESEARCH UNVEILS PUREREC DSN: THE MOST SELECTIVE DUPLEX-SPECIFIC NUCLEASE IRVINE, Calif. — Zymo Research, a leader in biotechnological advancement has launched a new nuclease called PureRec Duplex-Specific Nuclease (DSN) that selectively digests double stranded DNA (dsDNA). This new PureRec DSN promises unparalleled specificity in targeting duplex DNA, unlocking a variety of potential applications. DSN selectively digests dsDNA […]
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
Twist joins leading AI stakeholders to help advance the development and deployment of safe, trustworthy AI under new U.S. Government safety institute SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the company has joined the U.S. AI […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
